RESUMO
BACKGROUND: Unexpected allergic reactions to peanut are the most common cause of fatal food-related anaphylaxis. Mechanisms underlying the variable severity of peanut-allergic reactions remain unclear. OBJECTIVES: We sought to expand mechanistic understanding of reaction severity in peanut allergy. METHODS: We performed an integrated transcriptomic and epigenomic study of peanut-allergic children as they reacted in vivo during double-blind, placebo-controlled peanut challenges. We integrated whole-blood transcriptome and CD4+ T-cell epigenome profiles to identify molecular signatures of reaction severity (ie, how severely a peanut-allergic child reacts when exposed to peanut). A threshold-weighted reaction severity score was calculated for each subject based on symptoms experienced during peanut challenge and the eliciting dose. Through linear mixed effects modeling, network construction, and causal mediation analysis, we identified genes, CpGs, and their interactions that mediate reaction severity. Findings were replicated in an independent cohort. RESULTS: We identified 318 genes with changes in expression during the course of reaction associated with reaction severity, and 203 CpG sites with differential DNA methylation associated with reaction severity. After replicating these findings in an independent cohort, we constructed interaction networks with the identified peanut severity genes and CpGs. These analyses and leukocyte deconvolution highlighted neutrophil-mediated immunity. We identified NFKBIA and ARG1 as hubs in the networks and 3 groups of interacting key node CpGs and peanut severity genes encompassing immune response, chemotaxis, and regulation of macroautophagy. In addition, we found that gene expression of PHACTR1 and ZNF121 causally mediates the association between methylation at corresponding CpGs and reaction severity, suggesting that methylation may serve as an anchor upon which gene expression modulates reaction severity. CONCLUSIONS: Our findings enhance current mechanistic understanding of the genetic and epigenetic architecture of reaction severity in peanut allergy.
Assuntos
Anafilaxia/genética , Linfócitos T CD4-Positivos/fisiologia , Hipersensibilidade a Amendoim/genética , Adolescente , Alérgenos/imunologia , Arachis/imunologia , Criança , Estudos de Coortes , Metilação de DNA , Progressão da Doença , Epigênese Genética , Feminino , Redes Reguladoras de Genes , Humanos , Imunidade/genética , Imunização , Masculino , TranscriptomaRESUMO
OBJECTIVE: The pain numerical rating scale (NRS) is widely used in pain research and clinical settings to represent pain intensity. For an individual with chronic pain, NRS reporting requires representation of a complex subjective state as a numeral. To evaluate the process of NRS reporting, this study examined the relationship between reported pain NRS levels and imagined painful events reported by study subjects. DESIGN: A total of 149 subjects with chronic low back pain characterized by the NIH Research Task Force Recommended Minimal Dataset reported current pain NRS and provided imagined examples of painful experiences also attributing to these an NRS. We present a quantitative and qualitative analysis of the 797 pain examples provided by the study subjects. RESULTS: Study subjects tended to be able to imagine both highly painful 10/10 events and non-painful events with relative agreement across subjects. While NRS for the pain examples tended to increase with example severity, for many types of examples there was wide dispersion around the mean pain level. Examination of pain examples indicated unexpected relationships between current pain and the intensity and nature of the imagined painful events. CONCLUSIONS: Our results indicate that the pain NRS does not provide a reliably interpretable assessment of current physical pain intensity for an individual with chronic pain at a specific moment.
RESUMO
Neuropathic pain is a major, intractable clinical problem and its pathophysiology is not well understood. Although recent gene expression profiling studies have enabled the identification of novel targets for pain therapy, classical study designs provide unclear results owing to the differential expression of hundreds of genes across sham and nerve-injured groups, which can be difficult to validate, particularly with respect to the specificity of pain modulation. To circumvent this, we used two outbred lines of rats, which are genetically similar except for being genetically segregated as a result of selective breeding for differences in neuropathic pain hypersensitivity. SerpinA3N, a serine protease inhibitor, was upregulated in the dorsal root ganglia (DRG) after nerve injury, which was further validated for its mouse homolog. Mice lacking SerpinA3N developed more neuropathic mechanical allodynia than wild-type (WT) mice, and exogenous delivery of SerpinA3N attenuated mechanical allodynia in WT mice. T lymphocytes infiltrate the DRG after nerve injury and release leukocyte elastase (LE), which was inhibited by SerpinA3N derived from DRG neurons. Genetic loss of LE or exogenous application of a LE inhibitor (Sivelastat) in WT mice attenuated neuropathic mechanical allodynia. Overall, we reveal a novel and clinically relevant role for a member of the serpin superfamily and a leukocyte elastase and crosstalk between neurons and T cells in the modulation of neuropathic pain.
Assuntos
Proteínas de Fase Aguda/metabolismo , Inibidores Enzimáticos/farmacologia , Elastase de Leucócito/antagonistas & inibidores , Serpinas/metabolismo , Linfócitos T/citologia , Animais , Separação Celular , Dependovirus/genética , Feminino , Gânglios Espinais/metabolismo , Hiperalgesia/fisiopatologia , Hibridização In Situ , Masculino , Camundongos , Camundongos Transgênicos , Neuralgia , Neurônios/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Dor/fisiopatologia , Fenótipo , Reação em Cadeia da Polimerase , Ratos , Regulação para CimaRESUMO
The ability to perceive noxious stimuli is critical for an animal's survival in the face of environmental danger, and thus pain perception is likely to be under stringent evolutionary pressure. Using a neuronal-specific RNAi knock-down strategy in adult Drosophila, we recently completed a genome-wide functional annotation of heat nociception that allowed us to identify α2δ3 as a novel pain gene. Here we report construction of an evolutionary-conserved, system-level, global molecular pain network map. Our systems map is markedly enriched for multiple genes associated with human pain and predicts a plethora of novel candidate pain pathways. One central node of this pain network is phospholipid signaling, which has been implicated before in pain processing. To further investigate the role of phospholipid signaling in mammalian heat pain perception, we analysed the phenotype of PIP5Kα and PI3Kγ mutant mice. Intriguingly, both of these mice exhibit pronounced hypersensitivity to noxious heat and capsaicin-induced pain, which directly mapped through PI3Kγ kinase-dead knock-in mice to PI3Kγ lipid kinase activity. Using single primary sensory neuron recording, PI3Kγ function was mechanistically linked to a negative regulation of TRPV1 channel transduction. Our data provide a systems map for heat nociception and reinforces the extraordinary conservation of molecular mechanisms of nociception across different species.
Assuntos
Drosophila , Redes Reguladoras de Genes , Dor Nociceptiva , Fosfolipídeos , Transdução de Sinais , Animais , Capsaicina/toxicidade , Classe Ib de Fosfatidilinositol 3-Quinase/genética , Classe Ib de Fosfatidilinositol 3-Quinase/fisiologia , Drosophila/genética , Drosophila/fisiologia , Temperatura Alta , Humanos , Hipersensibilidade/genética , Camundongos , Neurônios Aferentes/metabolismo , Dor Nociceptiva/induzido quimicamente , Dor Nociceptiva/genética , Dor Nociceptiva/fisiopatologia , Fosfolipídeos/genética , Fosfolipídeos/metabolismo , Fosfolipídeos/fisiologia , Fosfotransferases (Aceptor do Grupo Álcool)/genética , Fosfotransferases (Aceptor do Grupo Álcool)/fisiologia , Canais de Cátion TRPV/genética , Canais de Cátion TRPV/metabolismo , Canais de Cátion TRPV/fisiologiaRESUMO
La investigación sobre la exposición a la violencia crónica en la comunidad se centra en las minorías étnicas y en los colectivos más pobres y azotados por la delincuencia, mientras que los programas de tratamiento y prevención se centran en los perpetradores de la violencia, y no en los adolescentes, que son sus víctimas directas o indirectas. Las intervenciones de tratamiento y prevención en el ámbito escolar son necesarias en el caso de menores con un alto riesgo de exposición a la violencia en su comunidad. En este trabajo se describe el proyecto Multiple Opportunities to Reach Excellence (MORE), un estudio epidemiológico longitudinal centrado en las comunidades y que ha sido puesto en práctica en la actualidad para comprender mejor el impacto de la exposición a la violencia crónica en el vecindario sobre el funcionamiento emocional, conductual, de consumo de drogas y académico de los menores y adolescentes, con el objetivo último de identificar los factores maleables de riesgo y protección en los que se puede incidir mediante programas de prevención e intervención (AU)
Research on chronic community violence exposure focuses on ethnic minority, impoverished, and crime-ridden communities while treatment and prevention focuses on the perpetrators of the violence, not on the youth who are its direct or indirect victims. School-based treatment and preventive interventions are needed for children at elevated risk for exposure to community violence. This paper describes The Multiple Opportunities to Reach Excellence (MORE) Project, a longitudinal, community epidemiological study currently being fielded to better understand the impact of childrens chronic exposure to community violence on their emotional, behavioral, substance use, and academic functioning with an overarching goal to identify malleable risk and protective factors which can be targeted in preventive and intervention programs (AU)
Assuntos
Humanos , Masculino , Feminino , Adolescente , Violência/psicologia , Comportamento do Adolescente , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Grupos de Risco , Etnicidade , Problemas Sociais , Política PúblicaRESUMO
This study evaluated the efficacy of a school-based anxiety prevention program among urban children exposed to community violence. Students who attended Title 1 public elementary schools were screened. Ninety-eight 3rd-5th-grade students (ages 8-12; 48% female; 92% African American) were randomized into preventive intervention versus wait list comparison groups. Students attended 13 biweekly one-hour group sessions of a modified version of FRIENDS, a cognitive-behavioral anxiety intervention program. Results indicated that both intervention and control groups manifested significant reductions in anxiety symptomatology and total exposure to community violence, along with improved standardized reading achievement scores. Additional gains observed only in the intervention group were increased standardized mathematics achievement scores, decreased life stressors, and reduced victimization by community violence. The intervention was equally efficacious for both genders and for children exposed to higher, compared to lower, levels of community violence. Implications for comprehensive, culturally and contextually relevant prevention programs and research are discussed.
Assuntos
Ansiedade/prevenção & controle , Negro ou Afro-Americano/psicologia , Instituições Acadêmicas/estatística & dados numéricos , Estudantes/estatística & dados numéricos , População Urbana/estatística & dados numéricos , Violência/psicologia , Adaptação Psicológica , Negro ou Afro-Americano/estatística & dados numéricos , Fatores Etários , Análise de Variância , Ansiedade/epidemiologia , Ansiedade/psicologia , Terapia Comportamental , Criança , Terapia Cognitivo-Comportamental , Manual Diagnóstico e Estatístico de Transtornos Mentais , Etnicidade , Humanos , Desenvolvimento de Programas , Avaliação de Programas e Projetos de Saúde , Psicometria , Características de Residência , Meio Social , Estresse Psicológico/complicações , Estresse Psicológico/psicologia , Estudantes/psicologia , Estados Unidos , Violência/prevenção & controle , Violência/estatística & dados numéricosRESUMO
Worldwide, acute, and chronic pain affects 20% of the adult population and represents an enormous financial and emotional burden. Using genome-wide neuronal-specific RNAi knockdown in Drosophila, we report a global screen for an innate behavior and identify hundreds of genes implicated in heat nociception, including the α2δ family calcium channel subunit straightjacket (stj). Mice mutant for the stj ortholog CACNA2D3 (α2δ3) also exhibit impaired behavioral heat pain sensitivity. In addition, in humans, α2δ3 SNP variants associate with reduced sensitivity to acute noxious heat and chronic back pain. Functional imaging in α2δ3 mutant mice revealed impaired transmission of thermal pain-evoked signals from the thalamus to higher-order pain centers. Intriguingly, in α2δ3 mutant mice, thermal pain and tactile stimulation triggered strong cross-activation, or synesthesia, of brain regions involved in vision, olfaction, and hearing.
Assuntos
Canais de Cálcio/genética , Proteínas de Drosophila/genética , Drosophila/genética , Dor/genética , Adulto , Animais , Dor nas Costas/genética , Canais de Cálcio/metabolismo , Proteínas de Drosophila/metabolismo , Técnicas de Silenciamento de Genes , Estudo de Associação Genômica Ampla , Temperatura Alta , Humanos , Camundongos , Polimorfismo de Nucleotídeo Único , Interferência de RNARESUMO
Not all patients with nerve injury develop neuropathic pain. The extent of nerve damage and age at the time of injury are two of the few risk factors identified to date. In addition, preclinical studies show that neuropathic pain variance is heritable. To define such factors further, we performed a large-scale gene profiling experiment which plotted global expression changes in the rat dorsal root ganglion in three peripheral neuropathic pain models. This resulted in the discovery that the potassium channel alpha subunit KCNS1, involved in neuronal excitability, is constitutively expressed in sensory neurons and markedly downregulated following nerve injury. KCNS1 was then characterized by an unbiased network analysis as a putative pain gene, a result confirmed by single nucleotide polymorphism association studies in humans. A common amino acid changing allele, the 'valine risk allele', was significantly associated with higher pain scores in five of six independent patient cohorts assayed (total of 1359 subjects). Risk allele prevalence is high, with 18-22% of the population homozygous, and an additional 50% heterozygous. At lower levels of nerve damage (lumbar back pain with disc herniation) association with greater pain outcome in homozygote patients is P = 0.003, increasing to P = 0.0001 for higher levels of nerve injury (limb amputation). The combined P-value for pain association in all six cohorts tested is 1.14 E-08. The risk profile of this marker is additive: two copies confer the most, one intermediate and none the least risk. Relative degrees of enhanced risk vary between cohorts, but for patients with lumbar back pain, they range between 2- and 3-fold. Although work still remains to define the potential role of this protein in the pathogenic process, here we present the KCNS1 allele rs734784 as one of the first prognostic indicators of chronic pain risk. Screening for this allele could help define those individuals prone to a transition to persistent pain, and thus requiring therapeutic strategies or lifestyle changes that minimize nerve injury.
Assuntos
Canal de Potássio Kv1.1/genética , Dor/genética , Polimorfismo Genético/genética , Valina/genética , Animais , Doença Crônica , Estudos de Coortes , Compreensão , Biologia Computacional/métodos , Comparação Transcultural , Modelos Animais de Doenças , Feminino , Gânglios Espinais/metabolismo , Gânglios Espinais/patologia , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Estudo de Associação Genômica Ampla , Genótipo , Humanos , Desequilíbrio de Ligação , Masculino , Proteínas de Neurofilamentos , Neuropeptídeos/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Dor/etiologia , RatosRESUMO
Community violence is recognized as a major public health problem (WHO, World Report on Violence and Health, 2002) that Americans increasingly understand has adverse implications beyond inner-cities. However, the majority of research on chronic community violence exposure focuses on ethnic minority, impoverished, and/or crime-ridden communities while treatment and prevention focuses on the perpetrators of the violence, not on the youth who are its direct or indirect victims. School-based treatment and preventive interventions are needed for children at elevated risk for exposure to community violence. In preparation, a longitudinal, community epidemiological study, The Multiple Opportunities to Reach Excellence (MORE) Project, is being fielded to address some of the methodological weaknesses presented in previous studies. This study was designed to better understand the impact of children's chronic exposure to community violence on their emotional, behavioral, substance use, and academic functioning with an overarching goal to identify malleable risk and protective factors which can be targeted in preventive and intervention programs. This paper describes the MORE Project, its conceptual underpinnings, goals, and methodology, as well as implications for treatment and preventive interventions and future research.
Assuntos
Afeto , Escolaridade , Psicologia da Criança , Transtornos Relacionados ao Uso de Substâncias/psicologia , Violência/psicologia , Fatores Etários , Baltimore , Criança , Desenvolvimento Infantil , Cognição , Feminino , Humanos , Estudos Longitudinais , Masculino , Características de Residência , Fatores de Risco , Fatores Sexuais , Ajustamento Social , Violência/prevenção & controleRESUMO
BACKGROUND: Adequate pain assessment is critical for evaluating the efficacy of analgesic treatment in clinical practice and during the development of new therapies. Yet the currently used scores of global pain intensity fail to reflect the diversity of pain manifestations and the complexity of underlying biological mechanisms. We have developed a tool for a standardized assessment of pain-related symptoms and signs that differentiates pain phenotypes independent of etiology. METHODS AND FINDINGS: Using a structured interview (16 questions) and a standardized bedside examination (23 tests), we prospectively assessed symptoms and signs in 130 patients with peripheral neuropathic pain caused by diabetic polyneuropathy, postherpetic neuralgia, or radicular low back pain (LBP), and in 57 patients with non-neuropathic (axial) LBP. A hierarchical cluster analysis revealed distinct association patterns of symptoms and signs (pain subtypes) that characterized six subgroups of patients with neuropathic pain and two subgroups of patients with non-neuropathic pain. Using a classification tree analysis, we identified the most discriminatory assessment items for the identification of pain subtypes. We combined these six interview questions and ten physical tests in a pain assessment tool that we named Standardized Evaluation of Pain (StEP). We validated StEP for the distinction between radicular and axial LBP in an independent group of 137 patients. StEP identified patients with radicular pain with high sensitivity (92%; 95% confidence interval [CI] 83%-97%) and specificity (97%; 95% CI 89%-100%). The diagnostic accuracy of StEP exceeded that of a dedicated screening tool for neuropathic pain and spinal magnetic resonance imaging. In addition, we were able to reproduce subtypes of radicular and axial LBP, underscoring the utility of StEP for discerning distinct constellations of symptoms and signs. CONCLUSIONS: We present a novel method of identifying pain subtypes that we believe reflect underlying pain mechanisms. We demonstrate that this new approach to pain assessment helps separate radicular from axial back pain. Beyond diagnostic utility, a standardized differentiation of pain subtypes that is independent of disease etiology may offer a unique opportunity to improve targeted analgesic treatment.
Assuntos
Dor Lombar/diagnóstico , Exame Neurológico , Medição da Dor/métodos , Índice de Gravidade de Doença , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Árvores de Decisões , Neuropatias Diabéticas/diagnóstico , Neuropatias Diabéticas/fisiopatologia , Diagnóstico Diferencial , Feminino , Humanos , Dor Lombar/fisiopatologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Síndromes de Compressão Nervosa/diagnóstico , Síndromes de Compressão Nervosa/fisiopatologia , Neuralgia Pós-Herpética/diagnóstico , Neuralgia Pós-Herpética/fisiopatologia , Estimulação Física , Estudos Prospectivos , Sensibilidade e Especificidade , Raízes Nervosas Espinhais , Inquéritos e Questionários , Adulto JovemRESUMO
Microarray expression profiles reveal substantial changes in gene expression in the ipsilateral dorsal horn of the spinal cord in response to three peripheral nerve injury models of neuropathic pain. However, only 54 of the 612 regulated genes are commonly expressed across all the neuropathic pain models. Many of the commonly regulated transcripts are immune related and include the complement components C1q, C3, and C4, which we find are expressed only by microglia. C1q and C4 are, moreover, the most strongly regulated of all 612 regulated genes. In addition, we find that the terminal complement component C5 and the C5a receptor (C5aR) are upregulated in spinal microglia after peripheral nerve injury. Mice null for C5 had reduced neuropathic pain sensitivity, excluding C3a as a pain effector. C6-deficient rats, which cannot form the membrane attack complex, have a normal neuropathic pain phenotype. However, C5a applied intrathecally produces a dose-dependent, slow-onset cold pain in naive animals. Furthermore, a C5aR peptide antagonist reduces cold allodynia in neuropathic pain models. We conclude that induction of the complement cascade in spinal cord microglia after peripheral nerve injury contributes to neuropathic pain through the release and action of the C5a anaphylatoxin peptide.
Assuntos
Anafilatoxinas/biossíntese , Complemento C5a/biossíntese , Microglia/metabolismo , Dor/metabolismo , Medula Espinal/metabolismo , Anafilatoxinas/genética , Anafilatoxinas/fisiologia , Animais , Células Cultivadas , Complemento C5a/genética , Complemento C5a/fisiologia , Regulação da Expressão Gênica/fisiologia , Hiperalgesia/genética , Hiperalgesia/metabolismo , Masculino , Proteínas de Membrana/biossíntese , Proteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Dor/genética , Medição da Dor/métodos , Ratos , Ratos Sprague-Dawley , Receptor da Anafilatoxina C5a , Receptores de Complemento/biossíntese , Receptores de Complemento/genéticaRESUMO
Axonal regeneration within the CNS fails due to the growth inhibitory environment and the limited intrinsic growth capacity of injured neurons. Injury to DRG peripheral axons induces expression of growth associated genes including members of the glial-derived neurotrophic factor (GDNF) signaling pathway and "preconditions" the injured cells into an active growth state, enhancing growth of their centrally projecting axons. Here, we show that preconditioning DRG neurons prior to culturing increased neurite outgrowth, which was further enhanced by GDNF in a bell-shaped growth response curve. In vivo, GDNF delivered directly to DRG cell bodies facilitated the preconditioning effect, further enhancing axonal regeneration beyond spinal cord lesions. Consistent with the in vitro results, the in vivo effect was seen only at low GDNF concentrations. We conclude that peripheral nerve injury upregulates GDNF signaling pathway components and that exogenous GDNF treatment selectively promotes axonal growth of injury-primed sensory neurons in a concentration-dependent fashion.
Assuntos
Gânglios Espinais/patologia , Fator Neurotrófico Derivado de Linhagem de Célula Glial/farmacologia , Regeneração Nervosa/efeitos dos fármacos , Neurônios Aferentes/efeitos dos fármacos , Traumatismos da Medula Espinal/patologia , Animais , Relação Dose-Resposta a Droga , Masculino , Neurônios Aferentes/fisiologia , Ratos , Ratos Sprague-DawleyRESUMO
We report that GTP cyclohydrolase (GCH1), the rate-limiting enzyme for tetrahydrobiopterin (BH4) synthesis, is a key modulator of peripheral neuropathic and inflammatory pain. BH4 is an essential cofactor for catecholamine, serotonin and nitric oxide production. After axonal injury, concentrations of BH4 rose in primary sensory neurons, owing to upregulation of GCH1. After peripheral inflammation, BH4 also increased in dorsal root ganglia (DRGs), owing to enhanced GCH1 enzyme activity. Inhibiting this de novo BH4 synthesis in rats attenuated neuropathic and inflammatory pain and prevented nerve injury-evoked excess nitric oxide production in the DRG, whereas administering BH4 intrathecally exacerbated pain. In humans, a haplotype of the GCH1 gene (population frequency 15.4%) was significantly associated with less pain following diskectomy for persistent radicular low back pain. Healthy individuals homozygous for this haplotype exhibited reduced experimental pain sensitivity, and forskolin-stimulated immortalized leukocytes from haplotype carriers upregulated GCH1 less than did controls. BH4 is therefore an intrinsic regulator of pain sensitivity and chronicity, and the GTP cyclohydrolase haplotype is a marker for these traits.
Assuntos
Biopterinas/análogos & derivados , GTP Cicloidrolase/fisiologia , Limiar da Dor/fisiologia , Dor/fisiopatologia , Adulto , Oxirredutases do Álcool/antagonistas & inibidores , Animais , Biopterinas/fisiologia , Inibidores Enzimáticos/farmacologia , GTP Cicloidrolase/antagonistas & inibidores , Haplótipos , Humanos , Manejo da Dor , Estudos Prospectivos , RatosAssuntos
Fatores de Troca do Nucleotídeo Guanina/fisiologia , Neurônios/fisiologia , Dor , Transdução de Sinais/fisiologia , Animais , Células Cultivadas , AMP Cíclico/análogos & derivados , AMP Cíclico/farmacologia , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Gânglios Espinais/citologia , Fatores de Troca do Nucleotídeo Guanina/efeitos dos fármacos , Neurônios/classificação , Neurônios/efeitos dos fármacos , Fosfolipase D/antagonistas & inibidores , Proteína Quinase C-épsilon/antagonistas & inibidores , Proteína Quinase C-épsilon/metabolismo , Transporte Proteico/efeitos dos fármacos , Ratos , Receptores Adrenérgicos beta/efeitos dos fármacos , Receptores Adrenérgicos beta/metabolismo , Transdução de Sinais/efeitos dos fármacosRESUMO
Microarrays have been used in a wide variety of experimental systems, but realizing their full potential is contingent on sophisticated and rigorous experimental design and data analysis. This article highlights what is needed to get the most out of microarrays in terms of accurately and effectively revealing differential gene expression and regulation in the nervous system.
Assuntos
Perfilação da Expressão Gênica , Sistema Nervoso/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Animais , Regulação da Expressão Gênica , Humanos , Análise de Sequência com Séries de Oligonucleotídeos/normas , Reprodutibilidade dos TestesRESUMO
BACKGROUND: Rat oligonucleotide microarrays were used to detect changes in gene expression in the dorsal root ganglion (DRG) 3 days following sciatic nerve transection (axotomy). Two comparisons were made using two sets of triplicate microarrays, naïve versus naïve and naïve versus axotomy. RESULTS: Microarray variability was assessed using the naïve versus naïve comparison. These results support use of a P < 0.05 significance threshold for detecting regulated genes, despite the large number of hypothesis tests required. For the naïve versus axotomy comparison, a 2-fold cut off alone led to an estimated error rate of 16%; combining a >1.5-fold expression change and P < 0.05 significance reduced the estimated error to 5%. The 2-fold cut off identified 178 genes while the combined >1.5-fold and P < 0.05 criteria generated 240 putatively regulated genes, which we have listed. Many of these have not been described as regulated in the DRG by axotomy. Northern blot, quantitative slot blots and in situ hybridization verified the expression of 24 transcripts. These data showed an 83% concordance rate with the arrays; most mismatches represent genes with low expression levels reflecting limits of array sensitivity. A significant correlation was found between actual mRNA differences and relative changes between microarrays (r2 = 0.8567). Temporal patterns of individual genes regulation varied. CONCLUSIONS: We identify parameters for microarray analysis which reduce error while identifying many putatively regulated genes. Functional classification of these genes suggest reorganization of cell structural components, activation of genes expressed by immune and inflammatory cells and down-regulation of genes involved in neurotransmission.